SurModics to Present at Jefferies Healthcare Conference
Webcast is Live on Wednesday, June 3, at 8:30 a.m. (ET)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--May 27, 2015--
SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that Gary Maharaj, president and chief
executive officer, and Andy LaFrence, vice president of finance and
chief financial officer, will make a presentation to the investment
community at the Jefferies Healthcare Conference in New York City on
Wednesday, June 3, 2015, at 8:30 a.m. ET (7:30 a.m. CT).
A live audio webcast of the presentation will be available by going to
the investor relations portion of the Company’s website at www.surmodics.com
and clicking on the webcast icon. In addition, the audio presentation
will be archived on the Company’s website for 90 days following the
About SurModics, Inc.
SurModics partners with the world's leading and emerging medical device,
diagnostic and life sciences companies to develop and commercialize
innovative products designed to improve lives by enabling the detection
and treatment of disease. The company’s core offerings include surface
modification coating technologies that impart lubricity, prohealing and
biocompatibility characteristics and components for in vitro
diagnostic test kits and microarrays. SurModics’ strategy is to build on
the product and technical leadership within these fields, and expand the
core offerings to generate opportunities for longer term sustained
growth. SurModics is headquartered in Eden Prairie, Minnesota. For more
information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150527005381/en/
Source: SurModics, Inc.
Andy LaFrence, 952-500-7000